AGREEMENT AND PLAN OF
MERGER
among
BIOMET, INC.,
LVB ACQUISITION, LLC
and
LVB ACQUISITION MERGER SUB,
INC.
Dated as of December 18,
2006
TABLE OF CONTENTS
|
|
|
|
Page
|
|
|
ARTICLE I
|
|
|
|
|
The Merger; Closing; Effective
Time
|
|
|
|
|
1.1.
|
|
The Merger
|
|
1
|
|
|
1.2.
|
|
Closing
|
|
1
|
|
|
1.3.
|
|
Effective Time
|
|
2
|
|
|
ARTICLE II
|
|
|
|
|
Articles of Incorporation and
Bylaws of the Surviving Corporation
|
|
|
|
|
2.1.
|
|
The Articles of
Incorporation
|
|
2
|
|
|
2.2.
|
|
The Bylaws
|
|
2
|
|
|
ARTICLE III
|
|
|
|
|
Officers and Directors
of the Surviving Corporation
|
|
|
|
|
3.1.
|
|
Directors
|
|
2
|
|
|
3.2.
|
|
Officers
|
|
2
|
|
|
ARTICLE IV
|
|
|
|
|
Effect of the Merger on Capital
Stock;
Exchange of Certificates
|
|
|
|
|
4.1.
|
|
Effect on Capital Stock
|
|
3
|
|
|
4.2.
|
|
Exchange of Certificates
|
|
3
|
|
|
4.3.
|
|
Treatment of Stock Plans
|
|
5
|
|
|
4.4.
|
|
Adjustments to Prevent
Dilution
|
|
5
|
|
|
ARTICLE V
|
|
|
|
|
Representations and
Warranties
|
|
|
|
|
5.1.
|
|
Representations and Warranties of
the Company
|
|
5
|
|
|
5.2.
|
|
Representations and Warranties of
Parent and Merger Sub
|
|
16
|
|
|
ARTICLE VI
|
|
|
|
|
Covenants
|
|
|
|
|
6.1.
|
|
Interim Operations
|
|
20
|
|
|
6.2.
|
|
Acquisition Proposals
|
|
22
|
|
|
6.3.
|
|
Proxy Statement
|
|
25
|
|
|
6.4.
|
|
Shareholders Meeting
|
|
25
|
|
|
6.5.
|
|
Filings; Other Actions;
Notification
|
|
25
|
|
|
6.6.
|
|
Access and Reports
|
|
27
|
|
|
6.7.
|
|
Stock Exchange De-listing
|
|
28
|
|
|
6.8.
|
|
Publicity
|
|
28
|
|
|
6.9.
|
|
Employee Benefits
|
|
28
|
|
|
6.10.
|
|
Expenses
|
|
29
|
|
|
6.11.
|
|
Indemnification; Directors’
and Officers’ Insurance
|
|
29
|
|
|
6.12.
|
|
Takeover Statutes
|
|
30
|
|
|
6.13.
|
|
Financing
|
|
30
|
|
|
|
|
|
|
|
|
|
|
i
|
6.14.
|
|
Shareholder Litigation
|
|
33
|
|
|
6.15.
|
|
Director Resignations
|
|
33
|
|
|
6.16.
|
|
Rule 16b-3
|
|
33
|
|
|
ARTICLE VII
|
|
|
|
|
Conditions
|
|
|
|
|
7.1.
|
|
Conditions to Each Party’s
Obligation to Effect the Merger
|
|
33
|
|
|
7.2.
|
|
Conditions to Obligations of Parent
and Merger Sub
|
|
34
|
|
|
7.3.
|
|
Conditions to Obligation of the
Company
|
|
35
|
|
|
ARTICLE VIII
|
|
|
|
|
Termination
|
|
|
|
|
8.1.
|
|
Termination by Mutual Consent
|
|
35
|
|
|
8.2.
|
|
Termination by Either Parent or the
Company
|
|
36
|
|
|
8.3.
|
|
Termination by the
Company
|
|
36
|
|
|
8.4.
|
|
Termination by Parent
|
|
36
|
|
|
8.5.
|
|
Effect of Termination and
Abandonment
|
|
37
|
|
|
ARTICLE IX
|
|
|
|
|
Miscellaneous and General
|
|
|
|
|
9.1.
|
|
Survival
|
|
39
|
|
|
9.2.
|
|
Modification or Amendment
|
|
39
|
|
|
9.3.
|
|
Waiver of Conditions
|
|
39
|
|
|
9.4.
|
|
Counterparts
|
|
39
|
|
|
9.5.
|
|
GOVERNING LAW AND VENUE; WAIVER OF
JURY TRIAL; REMEDIES; SPECIFIC PERFORMANCE
|
|
39
|
|
|
9.6.
|
|
Notices
|
|
41
|
|
|
9.7.
|
|
Entire Agreement
|
|
42
|
|
|
9.8.
|
|
No Third Party
Beneficiaries
|
|
42
|
|
|
9.9.
|
|
Obligations of Parent and of the
Company
|
|
43
|
|
|
9.10.
|
|
Transfer Taxes
|
|
43
|
|
|
9.11.
|
|
Definitions
|
|
43
|
|
|
9.12.
|
|
Severability
|
|
43
|
|
|
9.13.
|
|
Interpretation;
Construction
|
|
43
|
|
|
9.14.
|
|
Assignment
|
|
43
|
|
|
Annex A
|
|
Defined Terms
|
|
A-1
|
|
ii
AGREEMENT AND PLAN OF
MERGER
AGREEMENT AND PLAN OF MERGER
(hereinafter called this “ Agreement ”), dated
as of December 18, 2006, among Biomet, Inc., an Indiana
corporation (the “ Company ”), LVB Acquisition,
LLC, a Delaware limited liability company (“ Parent
”), and LVB Acquisition Merger Sub, Inc., an Indiana
corporation and a wholly owned subsidiary of Parent (“
Merger Sub ”). The Company and Merger Sub are
sometimes hereinafter collectively referred to as the “
Constituent Corporations ”.
RECITALS
WHEREAS, the parties to this
Agreement desire to effect the acquisition of the Company by Parent
through a merger of the Company and Merger Sub;
WHEREAS, in furtherance of the
foregoing and in accordance with the Indiana Business Corporation
Law (the “ IBCL ”) and the Delaware Limited
Liability Company Act, as the case may be, the respective boards of
directors of each of Parent, Merger Sub and the Company have
unanimously approved the Agreement, the merger of Merger Sub with
and into the Company with the Company as the Surviving
Corporation (the “ Merger ”) and the
transactions contemplated hereby upon the terms and subject to
the conditions set forth in this Agreement and have adopted and
declared advisable this Agreement;
WHEREAS, the board of directors of
the Company has approved in advance the transactions contemplated
by this Agreement for purposes of the provisions of
Section 23-1-43 of the IBCL;
WHEREAS, concurrently with the
execution of this Agreement, and as a condition to the willingness
of the Company to enter into this Agreement, each of Blackstone
Capital Partners V L.P., Goldman Sachs Investments Ltd., KKR 2006
Fund L.P. and TPG Partners V, L.P. (collectively, the “
Guarantors ”) is entering into a guarantee with the
Company (each a “ Guarantee ”) pursuant to which
each Guarantor is guaranteeing its pro rata portion of certain
obligations of Parent and Merger Sub in connection with this
Agreement; and
WHEREAS, the Company, Parent and
Merger Sub desire to make certain representations, warranties,
covenants and agreements in connection with this
Agreement.
NOW, THEREFORE, in consideration of
the premises, and of the representations, warranties, covenants and
agreements contained herein, the parties hereto agree as
follows:
ARTICLE I
The Merger; Closing; Effective
Time
1.1. The
Merger . Upon the terms and subject to the
conditions set forth in this Agreement, and in accordance with the
IBCL, Merger Sub shall be merged with and into the Company at the
Effective Time. Following the Effective Time, the separate
corporate existence of Merger Sub shall cease and the Company shall
continue as the surviving corporation in the Merger (the “
Surviving Corporation ”) and shall succeed to and
assume all the rights and obligations of Merger Sub in accordance
with the Section 23-1-40-6 of the IBCL.
1.2.
Closing . Unless otherwise mutually agreed in
writing between the Company and Parent, the closing for the Merger
(the “ Closing ”) shall take place at the
offices of Kirkland & Ellis LLP, Citigroup Center, 153
East 53rd Street, New York, New York, at 10:00 a.m. (Eastern
Time) on the second business day following the day on which the
last to be satisfied or waived of the conditions set forth in
ARTICLE VII (other than those conditions that by their
nature are to be satisfied at the Closing, but subject to the
fulfillment or waiver of those conditions) shall be satisfied or
waived in accordance with this Agreement; provided that,
notwithstanding the satisfaction or waiver of the conditions set
forth in ARTICLE VII , the
1
parties shall not be required to
effect the Closing until the earliest of (a) a date during the
Marketing Period specified by Parent on no less than three business
days’ notice to the Company, (b) the final day of the
Marketing Period and (c) the Termination Date, subject in each
case to the satisfaction or waiver of all the conditions set forth
in ARTICLE VII as of the date determined pursuant to this
proviso (the date on which the Closing occurs pursuant to this
Section 1.2 , the “ Closing Date ”).
For purposes of this Agreement, the term “ business
day ” shall mean any day ending at 11:59 p.m.
(Eastern Time) other than a Saturday or Sunday or a day on which
banks are required or authorized to close in the City of New
York.
1.3.
Effective Time . Subject to the provisions of
this Agreement, as soon as practicable on the Closing Date, the
Surviving Corporation shall file with the Secretary of State of the
State of Indiana articles of merger (the “ Articles of
Merger ”) executed and acknowledged by the parties in
accordance with the relevant provisions of the IBCL and, as soon as
practicable on or after the Closing Date, shall make all other
filings or recordings required under the IBCL. The Merger shall
become effective upon the filing of the Articles of Merger with the
Secretary of State of the State of Indiana, or at such later time
as Parent and the Company shall agree and shall specify in the
Articles of Merger (the time the Merger becomes effective being the
“ Effective Time ”).
ARTICLE II
Articles of Incorporation and
Bylaws of the Surviving Corporation
2.1. The
Articles of Incorporation . The articles of
incorporation of the Company shall be amended as of the Effective
Time as a result of the Merger so as to read in its entirely as the
articles of incorporation of Merger Sub (except that ARTICLE I
thereof shall be amended to read “The name of the Corporation
is Biomet, Inc.”) and, as so amended, shall be the
articles of incorporation of the Surviving Corporation (the “
Charter ”), until duly amended as provided therein or
by applicable Laws.
2.2. The
Bylaws . The parties hereto shall take all actions
necessary so that the bylaws of the Company in effect immediately
prior to the Effective Time shall be the bylaws of Merger Sub (the
“ Bylaws ”), until thereafter amended as
provided therein or by applicable Laws.
ARTICLE III
Officers and Directors
of the Surviving Corporation
3.1.
Directors . The parties hereto shall take all
actions necessary so that the board of directors of Merger Sub at
the Effective Time shall, from and after the Effective Time, be
elected or otherwise validly appointed as the directors of the
Surviving Corporation until their successors have been duly elected
or appointed and qualified or until their earlier death,
resignation or removal in accordance with the Charter and the
Bylaws.
3.2.
Officers . The officers of the Company at the
Effective Time shall, from and after the Effective Time, be the
officers of the Surviving Corporation until their successors shall
have been duly elected or appointed and qualified or until their
earlier death, resignation or removal in accordance with the
Charter and the Bylaws.
2
ARTICLE IV
Effect of the Merger on Capital
Stock;
Exchange of Certificates
4.1.
Effect on Capital Stock . At the Effective Time,
as a result of the Merger and without any action on the part of the
holder of any capital stock of the Company:
(a)
Merger Consideration . Each share of the common
stock, without par value, of the Company (a “ Share
” or, collectively, the “ Shares ”) issued
and outstanding immediately prior to the Effective Time (other than
Shares owned by Parent, Merger Sub or any other direct or indirect
wholly owned subsidiary of Parent and Shares owned by the Company
or any direct or indirect wholly owned subsidiary of the Company
(each, an “ Excluded Share ” and collectively,
the “ Excluded Shares ”)) shall be converted
into the right to receive $44.00 per Share in cash, less any
required withholding Taxes as described in
Section 4.2(f) and without interest (the “
Per Share Merger Consideration ”). At the Effective
Time, all of the Shares shall cease to be outstanding, shall be
cancelled and shall cease to exist, and each certificate (a “
Certificate ”) formerly representing any of the Shares
(other than Excluded Shares) shall thereafter represent only the
right to receive the Per Share Merger Consideration, without
interest.
(b)
Cancellation of Excluded Shares . Each Excluded
Share referred to in Section 4.1(a) shall, by
virtue of the Merger and without any action on the part of the
holder thereof, cease to be outstanding, shall be cancelled without
payment of any consideration therefor and shall cease to
exist.
(c)
Merger Sub . At the Effective Time, each share
of common stock, without par value, of Merger Sub issued and
outstanding immediately prior to the Effective Time shall be
converted into one share of common stock, without par value, of the
Surviving Corporation.
4.2.
Exchange of Certificates .
(a)
Paying Agent . At the Effective Time, Parent
shall deposit, or shall cause to be deposited, with a paying agent
selected by Parent with the Company’s prior approval (such
approval not to be unreasonably withheld or delayed) (the “
Paying Agent ”), for the benefit of the holders of
Shares, a cash amount in immediately available funds necessary for
the Paying Agent to make payments under
Section 4.1(a) (such cash being hereinafter
referred to as the “ Exchange Fund ”). The
Paying Agent shall invest the Exchange Fund as directed by Parent;
provided that such investments shall be in obligations of or
guaranteed by the United States of America, in commercial paper
obligations rated A-1 or P-1 or better by Moody’s Investors
Service, Inc. or Standard & Poor’s Corporation,
respectively. Any interest and other income resulting from such
investment shall become a part of the Exchange Fund, and any
amounts in excess of the amounts payable under
Section 4.1(a) shall be promptly returned to the
Surviving Corporation. To the extent that there are losses with
respect to any such investments, or the Exchange Fund diminishes
for any reason below the level required to make prompt cash payment
under Section 4.1(a) , Parent shall, or shall cause the
Surviving Corporation to promptly replace or restore the cash in
the Exchange Fund so as to ensure that the Exchange Fund is at all
times maintained at a level sufficient to make such payments under
Section 4.1(a) .
(b)
Exchange Procedures . Promptly after the
Effective Time (and in any event within five business days), the
Surviving Corporation shall cause the Paying Agent to mail to each
holder of record of Shares (other than holders of Excluded Shares)
(i) a letter of transmittal in customary form specifying that
delivery shall be effected, and risk of loss and title to the
Certificates shall pass, only upon delivery of the Certificates (or
affidavits of loss in lieu thereof as provided in
Section 4.2(e) ) to the Paying Agent, such letter of
transmittal to be in such form and have such other provisions as
Parent and the Company may reasonably agree, and
(ii) instructions for use in effecting the surrender of the
Certificates (or affidavits of loss in lieu thereof as provided in
Section 4.2(e) ) in exchange for the Per Share Merger
Consideration. Upon surrender of a Certificate (or affidavit of
loss in lieu thereof as provided in Section 4.2(e) ) to
the
3
Paying Agent in accordance with the
terms of such letter of transmittal, duly executed, the holder of
such Certificate shall be entitled to receive in exchange therefor
a cash amount in immediately available funds (after giving effect
to any required Tax withholdings as provided in
Section 4.2(f) ) equal to (A) the number of Shares
represented by such Certificate (or affidavit of loss in lieu
thereof as provided in Section 4.2(e) ) multiplied by
(B) the Per Share Merger Consideration, and the Certificate so
surrendered shall forthwith be cancelled. No interest will be paid
or accrued on any amount payable upon due surrender of the
Certificates. In the event of a transfer of ownership of Shares
that is not registered in the transfer records of the Company, a
check for any cash to be exchanged upon due surrender of the
Certificate may be issued to such transferee if the Certificate
formerly representing such Shares is presented to the Paying Agent,
accompanied by all documents reasonably required to evidence and
effect such transfer and to evidence that any applicable stock
transfer taxes have been paid or are not applicable.
(c)
Transfers . From and after the Effective Time,
there shall be no transfers on the stock transfer books of the
Company of the Shares that were outstanding immediately prior to
the Effective Time. If, after the Effective Time, any Certificate
is presented to the Surviving Corporation, Parent or the Paying
Agent for transfer, it shall be cancelled and exchanged for the
cash amount in immediately available funds to which the holder
thereof is entitled pursuant to this ARTICLE IV .
(d)
Termination of Exchange Fund . Any portion of
the Exchange Fund (including the proceeds of any investments
thereof) that remains unclaimed by the shareholders of the Company
for 180 days after the Effective Time shall be delivered to
the Surviving Corporation. Any holder of Shares (other than
Excluded Shares) who has not theretofore complied with this
ARTICLE IV shall thereafter look only to the Surviving
Corporation for payment of the Per Share Merger Consideration
(after giving effect to any required Tax withholdings as provided
in Section 4.2(f) ) upon due surrender of its
Certificates (or affidavits of loss in lieu thereof as provided in
Section 4.2(e) ), without any interest thereon.
Notwithstanding the foregoing, none of the Surviving Corporation,
Parent, the Paying Agent or any other Person shall be liable to any
former holder of Shares for any amount properly delivered to a
public official pursuant to applicable abandoned property, escheat
or similar Laws. For the purposes of this Agreement, the term
“ Person ” shall mean any individual,
corporation (including not-for-profit), general or limited
partnership, limited liability company, joint venture, estate,
trust, association, organization, Governmental Entity or other
entity of any kind or nature.
(e)
Lost, Stolen or Destroyed Certificates . In the
event any Certificate shall have been lost, stolen or destroyed,
upon the making of an affidavit of that fact by the Person claiming
such Certificate to be lost, stolen or destroyed and, if required
by Parent, the posting by such Person of a bond in customary amount
and upon such terms as may be required by Parent as indemnity
against any claim that may be made against it or the Surviving
Corporation with respect to such Certificate, the Paying Agent will
issue a check in the amount (after giving effect to any required
Tax withholdings as provided in Section 4.2(f) ) equal
to the number of Shares represented by such lost, stolen or
destroyed Certificate multiplied by the Per Share Merger
Consideration.
(f)
Withholding Rights . Each of Parent, Merger Sub,
the Surviving Corporation and the Paying Agent shall be entitled to
deduct and withhold from the consideration otherwise payable
pursuant to this Agreement to any holder of Shares such amounts as
it is required to deduct and withhold with respect to the making of
such payment under the Internal Revenue Code of 1986, as amended
(the “ Code ”), or any other applicable state,
local or foreign Tax Law. To the extent that amounts are so
withheld, such withheld amounts (i) shall be remitted by
Parent, Merger Sub, the Surviving Corporation or the Paying Agent,
as applicable, to the applicable Governmental Entity, and
(ii) shall be treated for all purposes of this Agreement as
having been paid to the holder of Shares in respect of which such
deduction and withholding was made by the Paying Agent, Surviving
Corporation, Merger Sub or Parent, as the case may be.
4
4.3.
Treatment of Stock Plans .
(a)
Options . At the Effective Time, each
outstanding option to purchase Shares under the Stock Plans, vested
or unvested (a “ Company Option ”), shall be
cancelled and shall only entitle the holder thereof to receive, as
soon as reasonably practicable after the Effective Time (but in any
event no later than three business days after the Effective Time),
an amount in cash equal to the product of (i) the total number
of Shares subject to the Company Option immediately prior to the
Effective Time multiplied by (ii) the excess, if any,
of the Per Share Merger Consideration over the exercise
price per Share under such Company Option, less applicable Taxes
required to be withheld with respect to such payment.
(b)
Corporate Actions . At or prior to the Effective
Time, the Company, the board of directors of the Company and the
compensation and stock option committee of the board of directors
of the Company, as applicable, shall adopt resolutions to implement
the provisions of Section 4.3(a) , it being understood
that the intention of the parties is that following the Effective
Time no holder of any Company Option or any participant in any
Stock Plan or other employee benefit arrangement of the Company
shall have any right thereunder to acquire any capital stock
(including any phantom stock or stock appreciation right) of the
Company, any Subsidiary or the Surviving Corporation. The Company
shall deliver to the holders of the Company Options appropriate
notices, at a time and in a form reasonably acceptable to Parent,
setting forth such holders’ rights pursuant to this
Agreement.
4.4.
Adjustments to Prevent Dilution . In the event
that the Company changes the number of Shares or securities
convertible or exchangeable into or exercisable for Shares issued
and outstanding prior to the Effective Time as a result of a
reclassification, stock split (including a reverse stock split),
stock dividend or distribution, recapitalization, merger, issuer
tender or exchange offer, or other similar transaction, the
Per Share Merger Consideration shall be equitably
adjusted.
ARTICLE V
Representations and
Warranties
5.1.
Representations and Warranties of the Company .
Except as set forth (i) in (A) the Company Reports filed
with the SEC from and after May 31, 2006 through and including
the date hereof or (B) the Form 8-K previously disclosed
to Parent and to be filed in connection with the announcement of
this Agreement (but, in any case, only to the extent (x) such
disclosure does not constitute a “risk factor” or a
“forward-looking statement” under the heading
“Forward-Looking Statements” in any of such Company
Reports and (y) the applicability of such disclosure to a
section or subsection of these representations and warranties is
reasonably apparent) or (ii) in the corresponding sections or
subsections of the disclosure letter delivered to Parent by the
Company prior to entering into this Agreement (the “
Company Disclosure Letter ”) (it being agreed that
disclosure of any item in any section or subsection of the Company
Disclosure Letter shall be deemed disclosure with respect to any
other section or subsection to which the relevance of such item is
reasonably apparent) the Company hereby represents and warrants to
Parent and Merger Sub that:
(a)
Organization, Good Standing and Qualification .
Each of the Company and its Subsidiaries is a legal entity duly
organized, validly existing and in good standing under the Laws of
its respective jurisdiction of organization and has all requisite
corporate or similar power and authority to own, lease and operate
its properties and assets and to carry on its business as presently
conducted and is qualified to do business and is in good standing
as a foreign corporation or similar entity in each jurisdiction
where the ownership, leasing or operation of its assets or
properties or conduct of its business requires such qualification,
except where the failure to be so organized, qualified or in good
standing, or to have such power or authority, would not,
individually or in the aggregate, have a Company Material Adverse
Effect. As used in this Agreement, the term (i) “
Subsidiary ” means, with respect to any Person, any
other Person of which at least a majority of the securities or
ownership interests having by their terms ordinary
voting
5
power to elect a majority of the
board of directors or other persons performing similar functions is
directly or indirectly owned or controlled by such Person and/or by
one or more of its Subsidiaries, (ii) “ Significant
Subsidiary ” is as defined in Rule 1.02(w) of
Regulation S-X promulgated pursuant to the Securities Exchange Act
of 1934, as amended (together with the rules and regulations
promulgated thereunder, the “ Exchange Act ”)
and (iii) “ Company Material Adverse Effect ”
means an event, change, effect, development, condition or
occurrence (each a “ Change ”) that is or
reasonably would be expected to be, individually or in the
aggregate, materially adverse to (x) the ability of the
Company to timely perform its obligations under and consummate the
transactions contemplated by this Agreement or (y) the
condition (financial or otherwise), business, assets, liabilities
or results of operations of the Company and its Subsidiaries taken
as a whole; provided that no Change to the extent resulting
from the following shall constitute or be taken into account in
determining whether there has been or reasonably would be expected
to be a Company Material Adverse Effect under clause (x) or
(y):
(A) changes
in the economy or financial markets generally in the United States
or other countries in which the Company or any of its Subsidiaries
conduct operations or that are the result of acts of war or
terrorism;
(B) general
changes or developments in any industry in which the Company and
its Subsidiaries operate;
(C) any loss
or threatened loss of, or adverse change or threatened adverse
change in, the relationship of the Company or any of its
Subsidiaries with its customers, partners, employees, financing
sources or suppliers, or any change in the Company’s credit
ratings, caused by the pendency or the announcement of the
transactions contemplated by this Agreement;
(D)
(1) any restatement of the Company’s financial
statements or any delay in filing periodic reports at the time
required by the Exchange Act solely to the extent resulting from
the failure to (x) properly document the measurement date for
any stock option grant, (y) record stock option expense (or
other items relating thereto) in accordance with GAAP or
(z) issue stock options in accordance with the terms of any
applicable Stock Plan (the failures described in clauses (x),
(y) and (z) being “ Option Accounting Issues
”) or (2) any civil investigation or civil litigation to
the extent arising out of or relating to any Options Accounting
Issues or applicable Laws relating thereto (including the IBCL and
the Exchange Act) or (3) any of the “Potential
Consequences” set forth in Section 5.1(e)
of the Company Disclosure Letter solely to the extent resulting
from Option Accounting Issues;
(E) the
failure by the Company to take any action prohibited by this
Agreement;
(F) changes
in any Law or GAAP or interpretation thereof after the date
hereof;
(G)
any failure by the Company to meet any estimates of revenues or
earnings for any period ending on or after the date of this
Agreement in and of itself; provided that the exception in
this clause (G) shall not prevent or otherwise affect a
determination that any Change underlying or contributing to such
failure has resulted in, or contributed to, a Company Material
Adverse Effect; and
(H) a
decline in the price or trading volume of the Company common stock
on the NASDAQ Global Select Market (the “ NASDAQ
”) in and of itself; provided that the exception in
this clause (H) shall not prevent or otherwise affect a
determination that any Change underlying or contributing to such
decline has resulted in, or contributed to, a Company Material
Adverse Effect;
6
unless, in the case of the foregoing
clauses (A), (B) and (F), such changes have a disproportionate
effect on the Company and its Subsidiaries, taken as a whole, when
compared to other companies operating in the same industries in
which the Company or its Subsidiaries operate.
(b)
Capital Structure . The authorized capital stock
of the Company consists of 500,000,000 Shares, of which 245,210,886
Shares were outstanding as of the close of business on
November 30, 2006, and 5,250 shares of preferred stock, none
of which were outstanding as of the date hereof. Since such date,
the Company has not issued any Shares other than the issuance of
Shares upon the exercise of Company Options outstanding on such
date and since December 8, 2006, the Company has not issued
any Company Options other than ordinary course “anniversary
grants” of Company Options that are not, in the aggregate,
material. All of the outstanding Shares have been duly authorized
and are validly issued, fully paid and nonassessable. As of the
date of this Agreement, other than Shares reserved for issuance
under the Biomet, Inc. 1998 Qualified and Non-Qualified Stock
Option Plan and the 2006 Equity Incentive Plan (collectively, the
“ Stock Plans ”), the Company has no Shares
reserved for issuance. Section 5.1(b) of the
Company Disclosure Letter contains a correct and complete list as
of December 8, 2006 of options, restricted stock, performance
stock units, restricted stock units and any other equity or
equity-based awards (including cash-settled awards), if any,
outstanding under the Stock Plans, including the holder, date of
grant, term, number of Shares and, where applicable, exercise
price. Each of the outstanding shares of capital stock or other
equity securities of each of the Company’s Subsidiaries is
duly authorized, validly issued, fully paid and nonassessable and
owned by the Company or by a direct or indirect wholly owned
Subsidiary of the Company, free and clear of any lien, charge,
pledge, security interest, claim or other encumbrance (each, a
“ Lien ”). Except as set forth above, there are
no preemptive or other outstanding rights, options, warrants,
conversion rights, stock appreciation rights, redemption rights,
repurchase rights, agreements, arrangements, calls, commitments or
rights of any kind that obligate the Company or any of its
Subsidiaries to issue or sell any shares of capital stock or other
equity securities of the Company or any of its Significant
Subsidiaries or any securities or obligations convertible or
exchangeable into or exercisable for, or giving any Person a right
to subscribe for or acquire, any equity securities of the Company
or any of its Significant Subsidiaries, or contractual obligations
of the Company or any of its Subsidiaries to make any payments
directly or indirectly based (in whole or in part) on the price or
value of the Shares or preferred shares, and no securities or
obligations evidencing such rights are authorized, issued or
outstanding. Upon any issuance of any Shares in accordance with the
terms of the Stock Plans, such Shares will be duly authorized,
validly issued, fully paid and nonassessable and free and clear of
any Liens. The Company does not have outstanding any bonds,
debentures, notes or other obligations for borrowed money the
holders of which have the right to vote (or convertible into or
exercisable for securities having the right to vote) with the
shareholders of the Company or any of its Significant Subsidiaries
on any matter. For purposes of this Agreement, a wholly owned
Subsidiary of the Company shall include any Subsidiary of the
Company of which all of the shares of capital stock of such
Subsidiary other than director qualifying shares are owned by the
Company (or a wholly owned Subsidiary of
the Company).
(c)
Corporate Authority; Approval and Fairness .
(i)
The Company has all requisite corporate power and authority and has
taken all corporate action necessary in order to execute and
deliver this Agreement and to perform its obligations under this
Agreement subject only, in the case of the consummation of the
Merger, to approval of the “plan of merger” (as such
term is used in Section 23-1-40 of the IBCL) contained in this
Agreement by the holders of seventy five percent (75%) of the
outstanding Shares entitled to vote on such matter at a
shareholders’ meeting duly called and held for such purpose
(the “ Requisite Company Vote ”). This Agreement
has been duly executed and delivered by the Company and constitutes
a valid and binding agreement of the Company enforceable against
the Company in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent transfer, reorganization,
7
moratorium and similar Laws of
general applicability relating to or affecting creditors’
rights and to general equity principles (the “ Bankruptcy
and Equity Exception ”).
(ii) The
board of directors of the Company has (A) unanimously
determined that the Merger is in the best interests of the Company
and its shareholders, unanimously adopted and declared advisable
this Agreement and the Merger and the other transactions
contemplated hereby and unanimously resolved to recommend approval
of the “plan of merger” (as such term is used in
Section 23-1-40 of the IBCL) contained in this Agreement to
the holders of Shares (the “ Company Board
Recommendation ”), (B) directed that this Agreement
be submitted to the holders of Shares for their approval of the
“plan of merger” contained in this Agreement at a
shareholders’ meeting duly called and held for such purpose,
(C) received the opinion of its financial advisor, Morgan
Stanley & Co. Incorporated, to the effect that the
consideration to be received by the holders of the Shares in the
Merger is fair from a financial point of view, as of the date of
such opinion, to such holders (the “ Opinion ”),
(D) assuming that Parent, Merger Sub and their respective
affiliates collectively beneficially own less than 10% of the
outstanding Shares, taken all necessary steps to render
Section 23-1-43 of the IBCL inapplicable to Parent and Merger
Sub and to the Merger, and (E) resolved to elect, to the
extent permitted by Law, for the Company not to be subject to any
Takeover Statute. It is agreed and understood that the Opinion is
for the benefit of the Company’s board of directors and may
not be relied on by Parent or Merger Sub.
(d)
Governmental Filings; No Violations; Certain Contracts
.
(i)
Other than the filings and/or notices (A) pursuant to
Section 1.3 , (B) under the Hart-Scott-Rodino
Antitrust Improvement Act of 1976, as amended (the “ HSR
Act ”), (C) under Council Regulation (EC) No
139/2004 (the “ ECMR ”), and any other
applicable foreign merger control laws, (D) under the Exchange
Act, (E) under the rules of the NASDAQ and
(F) required to be or customarily filed pursuant to any state
environmental transfer statutes (the “ Company
Approvals ”), no notices, reports or other filings are
required to be made by the Company with, nor are any consents,
registrations, approvals, permits or authorizations required to be
obtained by the Company from, any domestic or foreign governmental
or regulatory authority, agency, commission, body, court or other
legislative, executive or judicial governmental entity (each a
“ Governmental Entity ”), in connection with the
execution, delivery and performance of this Agreement by the
Company and the consummation of the Merger and the other
transactions contemplated hereby, except those that the failure to
make or obtain would not, individually or in the aggregate, have a
Company Material Adverse Effect or prevent, materially delay or
materially impair the consummation of the transactions contemplated
by this Agreement.
(ii) The
execution, delivery and performance of this Agreement by the
Company do not, and the consummation of the Merger and the other
transactions contemplated hereby will not, constitute or result in
(A) a breach or violation of, or a default under, the articles
of incorporation or bylaws of the Company or the comparable
governing instruments of any of its Significant Subsidiaries,
(B) with or without notice, lapse of time or both, a breach or
violation of, a termination (or right of termination) or a default
under, the creation or acceleration of any obligations or the
creation of a Lien on any of the assets of the Company or any of
its Significant Subsidiaries pursuant to any material agreement,
lease, license, contract, note, mortgage, indenture, arrangement or
other obligation (each, a “ Contract ”) binding
upon the Company or any of its Subsidiaries or, (C) assuming
compliance with the matters referred to in
Section 5.1(d)(i) , a violation of any Law to which the
Company or any of its Subsidiaries is subject, except, in the case
of clause (B) or (C) above, for any such breach,
violation, termination, default, creation, acceleration or change
that would not, individually or in the aggregate, have a Company
Material Adverse Effect or prevent, materially delay or materially
impair the consummation of the transactions contemplated by this
Agreement.
8
(e)
Company Reports; Financial Statements .
(i)
The Company has filed or furnished, as applicable, on a timely
basis all forms, statements, certifications, reports and documents
required to be filed or furnished by it with the Securities
Exchange Commission (the “ SEC ”) under the
Exchange Act or the Securities Act of 1933, as amended (the “
Securities Act ”) since May 31, 2004 (the “
Applicable Date ”) (the forms, statements,
certifications, reports and documents filed or furnished since the
Applicable Date and those filed or furnished subsequent to the date
hereof, including any amendments thereto, the “ Company
Reports ”). Each of the Company Reports, at the time of
its filing or being furnished complied or, if not yet filed or
furnished, will comply in all material respects with the applicable
requirements of the Securities Act, the Exchange Act and the
Sarbanes-Oxley Act of 2002, and any rules and regulations
promulgated thereunder applicable to the Company Reports. As of
their respective dates (or, if amended prior to the date hereof, as
of the date of such amendment), the Company Reports did not, and
any Company Reports filed or furnished with the SEC subsequent to
the date hereof will not, contain any untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary to make the statements made therein, in
light of the circumstances in which they were made, not
misleading.
(ii) The
Company is in compliance in all material respects with the
applicable listing and corporate governance rules and
regulations of the NASDAQ.
(iii)
Each of the consolidated balance sheets included in or incorporated
by reference into the Company Reports (including the related notes
and schedules) fairly presents in all material respects, or, in the
case of Company Reports filed after the date hereof, will fairly
present in all material respects the consolidated financial
position of the Company and its consolidated Subsidiaries as of its
date and each of the consolidated statements of operations,
shareholders’ equity and cash flows included in or
incorporated by reference into the Company Reports (including any
related notes and schedules) fairly presents in all material
respects, or in the case of Company Reports filed after the date
hereof, will fairly present in all material respects the
consolidated results of operations, retained earnings and changes
in financial position, as the case may be, of the Company and its
consolidated Subsidiaries for the periods set forth therein
(subject, in the case of unaudited statements, to the absence of
information or notes not required by GAAP to be included in interim
financial statements and to normal year-end adjustments), and in
each case have been prepared in accordance with U.S. generally
accepted accounting principles (“ GAAP ”)
applied on a consistent basis, except as may be noted
therein.
(iv) The
Company and its Subsidiaries have implemented and maintain a system
of internal accounting controls and financial reporting (as
required by Rule 13a-15(a) under the Exchange Act) that
are sufficient to provide reasonable assurances regarding the
reliability of financial reporting and the preparation of financial
statements in accordance with GAAP. The Company maintains
disclosure controls and procedures required by Rule 13a-15 or
15d-15 under the Exchange Act. Such disclosure controls and
procedures are effective to ensure that information required to be
disclosed by the Company is recorded and reported on a timely basis
to the individuals responsible for the preparation of the
Company’s filings with the SEC and other public disclosure
documents. The Company has disclosed, based on its most recent
evaluation prior to the date of this Agreement, to the
Company’s outside auditors and the audit committee of the
board of directors of the Company (A) any significant
deficiencies and material weaknesses in the design or operation of
its internal controls over financial reporting (as defined in
Rule 13a-15(f) of the Exchange Act) that would be
reasonably likely to materially and adversely affect the
Company’s ability to record, process, summarize and report
financial information and (B) any fraud, whether or not
material, that involves management or other employees who have a
significant role in the Company’s internal controls over
financial reporting
9
(f)
Absence of Certain Changes . Since May 31,
2006 there has not been a Company Material Adverse Effect. Since
August 31, 2006 through the date of this Agreement, the
Company and its Subsidiaries have conducted their respective
businesses only in, and have not engaged in any transaction other
than according to, the ordinary and usual course of such businesses
and there has not been:
(i)
any declaration, setting aside or payment of any dividend or other
distribution with respect to any shares of capital stock of the
Company or any of its Subsidiaries (except for dividends or other
distributions by any direct or indirect wholly owned Subsidiary to
the Company or to any wholly owned Subsidiary of the
Company);
(ii) any
material change in any method of accounting or accounting practice
by the Company or any of its Subsidiaries, except as may be
appropriate to conform to changes in statutory or regulatory
accounting rules or GAAP or regulatory requirements with
respect thereto;
(iii)
any redemption, repurchase or other acquisition of any shares of
capital stock of the Company or of any of its
Subsidiaries;
(iv) any
(A) grant or provision for severance or termination payments
or benefits to any director or officer of the Company (the “
Elected Officers ”) or employee, independent
contractor or consultant of the Company or any of its Subsidiaries,
except, in the case of employees who are not Elected Officers, in
the ordinary course of business consistent with past practice,
(B) increase in the compensation, perquisites or benefits
payable to any director, Elected Officer, employee, independent
contractor or consultant of the Company or any of its Subsidiaries,
except, in the case of employees who are not Elected Officers of
the Company, increases in base salary in the ordinary course of
business consistent with past practice, (C) grant of equity or
equity-based awards that may be settled in Shares, preferred shares
or any other securities of the Company or any of its Subsidiaries
or the value of which is linked directly or indirectly, in whole or
in part, to the price or value of any Shares, preferred shares or
other Company securities or Subsidiary securities,
(D) acceleration in the vesting or payment of compensation
payable or benefits provided or to become payable or provided to
any current or former director, officer, employee, independent
contractor or consultant, (E) change in the terms of any
outstanding Company Option, or (F) establishment or adoption
of any new arrangement that would be a Benefit Plan or terminate or
materially amend any existing Benefit Plan (other than changes made
in the ordinary course of business consistent with past practice or
as may be necessary to comply with applicable Laws, in either case
that do not materially increase the costs of any such Benefit
Plans); or
(v)
any material Tax election made or revoked by the Company or any of
its Subsidiaries or any settlement or compromise of any material
Tax liability made by the Company or any of its
Subsidiaries.
(g)
Litigation and Liabilities .
(i)
There are no civil, criminal or administrative actions, suits,
claims, hearings, arbitrations, investigations, inquiries or other
proceedings pending or, to the Knowledge of the Company, threatened
against the Company or any of its Subsidiaries, which would,
individually or in the aggregate, have a Company Material Adverse
Effect. Neither the Company nor any of its Subsidiaries is a party
to or subject to the provisions of any judgment, order, writ,
injunction, decree or award of any Governmental Entity which would,
individually or in the aggregate, have a Company Material Adverse
Effect.
10
(ii) Neither
the Company nor any of its Subsidiaries has any liabilities or
obligations of any nature (whether accrued, absolute, contingent or
otherwise), whether or not required by GAAP to be set forth on a
consolidated balance sheet of the Company and its Subsidiaries or
in the notes thereto, other than liabilities and obligations
(A) set forth in the Company’s consolidated balance
sheet as of May 31, 2006 included in the Company Reports,
(B) incurred in the ordinary course of business consistent
with past practice since May 31, 2006, (C) incurred in
connection with the Merger or the transactions contemplated by this
Agreement, or (D) that would not, individually or in the
aggregate, have a Company Material Adverse Effect.
The term “Knowledge”
when used in this Agreement with respect to the Company shall mean
the actual knowledge of those persons set forth in
Section 5.1(g) of the Company Disclosure Letter
without obligation of any further review or inquiry, and does not
include information of which they may be deemed to have
constructive knowledge only.
(h)
Employee Benefits .
(i)
All material employee benefit plans covering current or former
officers, directors, employees of the Company or its Subsidiaries
(collectively, the “ Employees ”) or current or
former independent contractors or consultants of the Company or its
Subsidiaries, or under which there is a financial obligation of the
Company or any of its Subsidiaries, including, but not limited to,
“employee benefit plans” within the meaning of
Section 3(3) of the Employee Retirement Income Security
Act of 1974, as amended (“ ERISA ”), whether or
not subject to ERISA, and deferred compensation, stock option,
stock purchase, stock appreciation rights, other stock or stock
based, incentive and bonus, change in control, salary continuation,
termination or severance plan, program, policy, practice,
arrangement or agreement or other material employment agreement
(the “ Benefits Plans ”), other than Benefit
Plans maintained outside of the United States primarily for the
benefit of Employees working outside of the United States (such
plans hereinafter being referred to as “ Non-U.S. Benefit
Plans ”), are listed in
Section 5.1(h)(i) of the Company Disclosure
Letter. True and complete copies of all Benefit Plans listed in
Section 5.1(h)(i) of the Company Disclosure
Letter have been made available to Parent.
(ii) Except
for such matters that would not, individually or in the aggregate,
have a Company Material Adverse Effect:
(A) all
Benefits Plans, other than “multiemployer plans” within
the meaning of Section 3(37) of ERISA (each, a “
Multiemployer Plan ”) and Non U.S. Benefit Plans,
(collectively, “ U.S. Benefit Plans ”), have
been established, maintained and operated in compliance with their
terms, ERISA, the Code and all other applicable Laws and each U.S.
Benefit Plan that is intended to qualify under Section 401 of
the Code has received a favorable determination letter from the
Internal Revenue Service or may rely on a favorable opinion letter
issued by the Internal Revenue Service and, to the Knowledge of the
Company, nothing has occurred since the date of such letter that
has or is likely to adversely affect such qualification;
(B) neither
the Company nor any of its Subsidiaries has engaged in a
transaction that, assuming the taxable period of such transaction
expired as of the date hereof, could subject the Company or any
Subsidiary to a tax or penalty imposed by either Section 4975
of the Code or Section 502(i) of ERISA or any other
similar provision of non-U.S. Law;
(C) neither
the Company nor any of its Subsidiaries has or is expected to incur
any liability under Title IV of ERISA with respect to any
“single-employer plan”, within the meaning of
Section 4001(a)(15) of ERISA, any Multiemployer Plan or any
“multiple employer plan”, within the meaning of
Section 4063/4064 of ERISA or section 413(c) of the Code,
in
11
each case currently or formerly
maintained or contributed to by any of them or any other entity
which is considered one employer with the Company under
Section 4001 of ERISA or Section 414 of the Code (an
“ ERISA Affiliate ”;
(D) the
Company and its Subsidiaries do not have any unsatisfied withdrawal
liability with respect to a Multiemployer Plan under
Subtitle E of Title IV of ERISA;
(E) all
Non-U.S. Benefit Plans have been established, maintained and
operated in compliance with their terms and all applicable Laws and
each Non-U.S. Benefit Plan intended to qualify for favorable tax
treatment outside the United States is so qualified; and
(F) All
Non-U.S. Benefit Plans are listed in
Section 5.1(h)(ii)(F) of the Company Disclosure
Letter. The Company has made available true and complete summaries
of all material Non-U.S. Benefit Plans.
(i)
Compliance with Laws; Licenses . The businesses
of each of the Company and its Subsidiaries have not been since the
Applicable Date, and are not being, conducted in violation of any
federal, state, local or foreign law, statute or ordinance, common
law, or any rule, regulation, standard, judgment, order, writ,
injunction, decree, arbitration award, agency requirement, license
or permit of any Governmental Entity (collectively, “
Laws ”), except for violations that would not,
individually or in the aggregate, have a Company Material Adverse
Effect. Except with respect to regulatory matters covered by
Section 6.5 , no investigation by any Governmental
Entity with respect to the Company or any of its Subsidiaries or
any Benefit Plan is pending or, to the Knowledge of the Company,
threatened except for those the outcome of which would not,
individually or in the aggregate, have a Company Material Adverse
Effect. The Company and its Subsidiaries each has obtained and is
in compliance with all permits, certifications, approvals,
registrations, consents, authorizations, franchises, variances,
exemptions and orders issued or granted by a Governmental Entity
(“ Licenses ”) necessary to conduct its business
as presently conducted, except those the absence of which would
not, individually or in the aggregate, have a Company Material
Adverse Effect.
(j)
Takeover Statutes . Assuming that Parent, Merger
Sub and their respective affiliates beneficially own less than 10%
of the outstanding Shares, no “fair price,”
“moratorium,” “control share acquisition”
or other similar Indiana anti-takeover statute or regulation (each,
a “ Takeover Statute ”) or any anti-takeover
provision in the Company’s articles of incorporation or
bylaws is applicable to the Merger or the other transactions
contemplated by this Agreement. The adoption of this Agreement and
the Merger by the Company’s board of directors represents all
the actions necessary to render inapplicable to this Agreement, the
Merger and the other transactions contemplated by this Agreement,
the restrictions on “business combinations” (as defined
in Section 23-1-43-5 of the ICBL) set forth in
Section 23-1-43-18 of the IBCL to the extent, if any, such
restrictions would otherwise be applicable to this Agreement, the
Merger, the other transactions contemplated by this Agreement or to
Parent or Merger Sub or any of their Affiliates in connection
therewith.
(k)
Rights Agreement . The Company has taken all
actions necessary to redeem all rights outstanding under the Rights
Agreement, dated as of December 16, 1999 (as amended
September 2, 2002), between the Company and American Stock
Transfer and Trust Company, as successor rights agent (the “
Rights Agreement ”), and to cause the Rights Agreement
to be rendered inapplicable to this Agreement, the Merger and the
transactions contemplated by this Agreement.
(l)
Environmental Matters . Except in each case for
such matters that would not, individually or in the aggregate, have
a Company Material Adverse Effect: (A) to the Knowledge of the
Company, the Company and its Subsidiaries have complied at all
times since the Applicable Date with all applicable Environmental
Laws; (B) to the Knowledge of the Company, the Company and its
Subsidiaries possess all permits, licenses, registrations,
identification numbers, authorizations and approvals required under
applicable Environmental Laws for the operation of the business as
presently conducted; (C) neither the
12
Company nor any Subsidiary has
received any written claim, notice of violation or citation
concerning any violation or alleged violation of any applicable
Environmental Law or concerning any actual or alleged liability of
the Company or any of its Subsidiaries arising under or pursuant to
any Environmental Law, in each case since the Applicable Date; and
(D) there are no writs, injunctions, decrees, orders or
judgments outstanding, or any actions, suits or proceedings pending
or, to the Knowledge of the Company, threatened, concerning
noncompliance by, or actual or potential liability of, the Company
or any Subsidiary with any Environmental Law.
As used herein, the term “
Environmental Law ” means, as currently in effect, any
applicable law, regulation, code, license, permit, order, judgment,
decree or injunction from any Governmental Entity
(A) concerning the protection of the environment, (including
air, water, soil and natural resources) or (B) the use,
storage, handling, release or disposal of Hazardous
Substances.
As used herein, the term “
Hazardous Substance ” means any substance presently
listed, defined, designated or classified as hazardous, toxic or
radioactive under any applicable Environmental Law including
petroleum and any derivative or by-products thereof.
(m)
Taxes .
(i)
The Company and each of its Subsidiaries: (A) have prepared in
good faith and duly and timely filed (taking into account any
extension of time within which to file) all Tax Returns required to
be filed by any of them except where such failures to prepare or
file Tax Returns would not, individually or in the aggregate, have
a Company Material Adverse Effect; (B) all such Tax Returns
have been true, correct and complete in all material respects;
(C) have timely paid all Taxes that are shown on all such Tax
Returns and withheld all amounts that the Company or any of its
Subsidiaries are obligated to withhold from amounts owing to any
employee, creditor, shareholder, affiliate or third party, except
with respect to matters contested in good faith as to which
adequate reserves have been established on the balance sheet of the
Company as of August 31, 2006 in accordance with GAAP and
except where such failure to so pay or remit would not,
individually or in the aggregate, have a Company Material Adverse
Effect; and (D) have not waived any statute of limitations
with respect to any material amount of Taxes or agreed to any
extension of time with respect to any material amount of Tax
assessment or deficiency.
(ii) The
Company and its Subsidiaries have no liability for any Tax or any
portion of a Tax (or any amount calculated with reference to any
portion of a Tax) of any Person other than the Company or its
Subsidiaries, including under Treasury Regulations
Section 1.1502-6 (or any similar provision of state, local or
foreign law), as transferee or successor, by contract or otherwise,
except for such amounts as do not, individually or in the
aggregate, have a Company Material Adverse Effect.
(iii)
As of the date hereof, there are not pending or, to the Knowledge
of the Company, threatened in writing, any audits, examinations,
investigations or other proceedings in respect of Taxes or Tax
matters. The Company has made available to Parent true and correct
copies of the United States federal income Tax Returns filed by the
Company and its Subsidiaries for each of the fiscal years ended
May 31, 2005 and 2004.
(iv) Neither
the Company nor any of its Subsidiaries has constituted either a
“distributing corporation” or a “controlled
corporation” (within the meaning of
Section 355(a)(1)(A) of the Code) in a distribution of
stock qualifying for tax-free treatment under Section 355 of
the Code occurring any time during the two-year period ending on
the date of this Agreement.
(v)
Neither the Company nor its Subsidiaries have engaged in any
“listed transaction” as such term is defined in
Treasury Regulations section 1.6011-4 or any similar provision of
state, local or foreign tax law.
13
As used in this Agreement,
(A) the term “ Tax ” (including, with
correlative meaning, the term “ Taxes ”)
includes all federal, state, local and foreign income, profits,
franchise, gross receipts, environmental, customs duty, capital
stock, escheat, severances, stamp, payroll, sales, employment,
unemployment, disability, use, property, withholding, excise,
production, value added, occupancy and other taxes, duties or
assessments of any nature whatsoever, together with all interest,
penalties and additions imposed with respect to such amounts and
any interest in respect of such penalties and additions, and
(B) the term “ Tax Return ” includes all
returns and reports (including elections, declarations,
disclosures, schedules, estimates and information returns) required
to be supplied to a Tax authority relating to Taxes.
(n)
Labor Matters . Neither the Company nor any of
its Subsidiaries is a party to or otherwise bound by any collective
bargaining agreement with a labor union or labor organization, nor
are there any U.S. employees of the Company or any of its
Subsidiaries represented by a works’ council, representative
body or other labor organization, and there are, to the Knowledge
of the Company, no material activities or material proceedings of
any labor union, works council, representative body or other
organization to organize any employees of the Company or any of its
Subsidiaries or compel the Company or any of its Subsidiaries to
bargain with any such union, works council or representative body.
Neither the Company nor any of its Subsidiaries is the subject of
any material proceeding asserting that the Company or any of its
Subsidiaries has committed an unfair labor practice or seeking to
compel it to bargain with any labor union or labor organization nor
is there pending or, to the Knowledge of the Company, threatened,
nor has there been since the Applicable Date, any labor strike,
dispute, walk-out, work stoppage, slow-down, lockout or any other
similar event involving the Company or any of its
Subsidiaries.
(o)
Intellectual Property .
(i)
To the Knowledge of the Company, (A) the Company and its
Subsidiaries have sufficient rights to use all material
Intellectual Property necessary for the operation of their
businesses as presently conducted, and (B) except as would not
have a Company Material Adverse Effect, all of such rights shall
survive unchanged the consummation of the transactions contemplated
by this Agreement. No written claim has been asserted, or to the
Knowledge of the Company threatened, against the Company or its
Subsidiaries concerning the ownership, validity, registerability,
enforceability, infringement, use or licensed right to use any
Intellectual Property that would have a Company Material Adverse
Effect. To the Knowledge of the Company, no person is violating any
Intellectual Property owned by the Company except as would not have
a Company Material Adverse Effect.
(ii) For
purposes of this Agreement, the following term has the following
meaning:
“ Intellectual Property
” means all: (A) trademarks, service marks, brand names,
Internet domain names, logos, symbols, trade dress, trade names,
and other indicia of origin, all applications and registrations for
the foregoing, and all goodwill associated therewith and symbolized
thereby, including all renewals of same; (B) inventions and
discoveries, and all patents, registrations, invention disclosures
and applications therefor, including divisions, continuations,
continuations-in-part and renewal applications, and including
renewals, extensions, reexaminations and reissues;
(C) confidential information, trade secrets and know-how,
including processes, schematics, business methods, drawings,
prototypes, models, designs, customer lists and supplier lists;
(D) published and unpublished works of authorship (including,
databases and other compilations of information), copyrights
therein and thereto, and registrations and applications therefor,
and all renewals, extensions, restorations and reversions thereof;
and (E) all other intellectual property or proprietary
rights.
(p)
Insurance . The Company and each of its
Subsidiaries is covered by valid and currently effective insurance
policies issued in favor of the Company or one or more of its
Subsidiaries that are customary and adequate for companies of
similar size in the industry and locales in which the Company and
its Subsidiaries operate. All such material fire and casualty,
general liability, director and officer
14
liability, business interruption,
product liability and sprinkler and water damage insurance policies
maintained by the Company or any of its Subsidiaries (collectively,
the “ Insurance Policies ”) are in full force
and effect and all premiums due with respect to all Insurance
Policies have been paid, with such exceptions that would not,
individually or in the aggregate, have a Company Material Adverse
Effect.
(q)
Brokers and Finders . Neither the Company nor
any of its officers, directors or employees has employed any broker
or finder or incurred any liability for any brokerage fees,
commissions or finders fees in connection with the Merger or the
other transactions contemplated in this Agreement except that the
Company has employed Morgan Stanley & Co. Incorporated as
its financial advisor.
(r)
Material Contracts . The Company has made
available to Parent true, correct and complete copies of, all
contracts, agreements, commitments, arrangements, leases (including
with respect to personal property) and other instruments to which
the Company or any of its Subsidiaries is a party or by which the
Company, any of its Subsidiaries or any of their respective
properties or assets is bound that (A) contain covenants that
which, following the consummation of the Merger, could restrict the
ability of Parent or any of its affiliates as of immediately prior
to the Effective Time to compete or operate in any business or with
any person or in any geographic area, or to sell, supply or
distribute any service or product or to otherwise operate or expand
its current or future businesses; (B) involve any exchange
traded, over-the-counter or other swap, cap, floor, collar, futures
contract, forward contract, option or any other derivative
financial instrument; (C) relate to indebtedness for borrowed
money or similar obligations; or (D) involve, since
January 1, 2004, the acquisition or disposition, directly or
indirectly (by merger or otherwise), of assets or capital stock or
other equity interests of another person for aggregate
consideration under such contract in excess of $50 million (other
than acquisitions or dispositions of assets in the ordinary course
of business, including acquisitions and dispositions of
inventory).
(s)
Proxy Statement; Other Filings . The letter to
shareholders, notice of meeting, proxy statement and form of proxy
that will be provided to shareholders of the Company in connection
with the Merger (including any amendments or supplements) and any
schedules required to be filed with the SEC in connection therewith
(collectively, the “ Proxy Statement ”), at the
time the Proxy Statement is first mailed and at the time of the
Shareholders Meeting, and any other document to be filed with the
SEC in connection with the Merger (the “ Other Filings
”), at the time of its filing with the SEC, will not contain
any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which
they are made, not misleading, except that no representation or
warranty is made by the Company with respect to information
supplied in writing by Parent, Merger Sub or any Affiliate of
Parent or Merger Sub expressly for inclusion therein. The Proxy
Statement and the Other Filings will comply as to form in all
material respects with the provisions of the Exchange Act and the
rules and regulations of the SEC promulgated
thereunder.
(t)
Regulatory Compliance .
(i)
The Company is conducting its business and operations in material
compliance with the Federal Food, Drug, and Cosmetic Act (the
“ FD&C Act ”), 21 U.S.C. §301 et. seq.,
and applicable regulations promulgated thereunder by the United
States Food and Drug Administration (the “ FDA
”) (collectively, “ FDA Law and Regulation
”). Each Medical Device, as that term is defined in 21 U.S.C.
§ 321(h) of the FD&C Act, that is manufactured,
tested, distributed and/or marketed by the Company, is being
manufactured, tested, distributed and/or marketed by the Company in
material compliance with applicable FDA Law and Regulation,
including those relating to: (A) good manufacturing practices;
(B) regulatory approvals or clearances to market Medical
Devices in the United States; (C) investigational studies;
(D) labeling; (E) record keeping; and (F) filing of
reports to the FDA. The Company has not received any notice or
communication from the FDA alleging material noncompliance with any
applicable FDA Law and Regulation. The Company has no Knowledge of
any pending or completed FDA proceedings seeking the recall,
withdrawal, suspension
15
or seizure of any Medical Device
against the Company. To the Knowledge of the Company, the Company
is not the subject of any current enforcement proceedings by the
FDA.
(ii) To the
Knowledge of the Company, no officer, employee or agent of the
Company has: (A) made any untrue statement of material fact or
fraudulent statement to the FDA or any other Governmental Entity
responsible for FDA Law and Regulation; (B) failed to disclose
a material fact required to be disclosed to the FDA or any other
Governmental Entity responsible for FDA Law and Regulation; or
(C) committed an act, made a statement or failed to make a
statement that would reasonably be expected to provide the basis
for the FDA or any other Governmental Entity responsible for FDA
Law or Regulation to invoke its policy respecting “Fraud,
Untrue Statements of Material Facts, Bribery, and Illegal
Gratuities,” as set forth in 56 Fed.Reg. 46191
(September 10, 1991).
(iii)
Except as would not, individually or in the aggregate, have a
Company Material Adverse Effect, neither the Company nor any of its
directors, members, employees, agents, officers or managers has
engaged in any activities which are prohibited under any Law
relating to healthcare regulatory matters, including, without
limitation, (a) 42 U.S.C. §§ 1320a-7, 7a and 7b,
which are commonly referred to as the “Federal Fraud
Statutes”; (b) 42 U.S.C. § 1395nn, which is
commonly referred to as the “Stark Statute”;
(c) 31 U.S.C. §§ 3729-3733, which is commonly
referred to as the “Federal False Claims Act”;
(d) 42 U.S.C. §§ 1320d through 1320d-8 and 42 C.F.R.
§§ 160, 162 and 164, which are commonly referred to as
the “Health Insurance Portability and Accountability Act of
1996”; (e) any conduct for which debarment is required
or authorized under 21 U.S.C. § 335a; and (f) any related
federal, state or local statutes or regulations.
(u)
Properties . Except as would not, individually
or in the aggregate, have a Company Material Adverse Effect, the
Company or one of its Subsidiaries (i) has good title to all
the properties and assets reflected in the latest audited balance
sheet included in the Company Reports as being owned by the Company
or one of its Subsidiaries or acquired after the date thereof that
are material to the Company’s business on a consolidated
basis (except properties sold or otherwise disposed of since the
date thereof in the ordinary course of business), free and clear of
all Liens, except (A) statutory liens securing payments not
yet due, (B) such imperfections or irregularities of title,
claims, liens, charges, security interests, easements, covenants
and other restrictions or encumbrances as do not materially affect
the use of the properties or assets subject thereto or affected
thereby or otherwise materially impair business operations at such
properties and (C) mortgages, or deeds of trust, security
interests or other encumbrances on title related to indebtedness
reflected on the consolidated financial statements of the Company,
and (ii) is the lessee of all leasehold estates reflected in
the latest audited financial statements included in the Company
Reports or acquired after the date thereof that are material to its
business on a consolidated basis (except for leases that have
expired by their terms since the date thereof or been assigned,
terminated or otherwise disposed of in the ordinary course of
business consistent with past practice) and is in possession of the
properties purported to be leased thereunder, and each such lease
is valid without default thereunder by the lessee or, to the
Company’s Knowledge, the lessor.
(v)
Affiliate Transactions . No executive officer or
director of the Company or any of its Subsidiaries or any person
beneficially owning 5% or more of the Shares is a party to any
material Contract with or binding upon the Company or any of its
Subsidiaries or any of their respective properties or assets or has
any material interest in any material property owned by the Company
or any of its Subsidiaries or has engaged in any material
transaction with any of the foregoing within the last twelve
months.
5.2.
Representations and Warranties of Parent and Merger Sub
. Except as set forth in the corresponding sections or
subsections of the disclosure letter delivered to the Company by
Parent prior to entering into this Agreement (the “ Parent
Disclosure Letter ”) (it being agreed that disclosure of
any item in
16
any section or subsection of the
Parent Disclosure Letter shall be deemed disclosure with respect to
any other section or subsection to which the relevance of such item
is reasonably apparent), Parent and Merger Sub each hereby
represent and warrant to the Company that:
(a)
Organization, Good Standing and Qualification .
Each of Parent and Merger Sub is a legal entity duly organized,
validly existing and in good standing under the Laws of its
respective jurisdiction of organization and has all requisite
corporate or similar power and authority to own, lease and operate
its properties and assets and to carry on its business as presently
conducted and is qualified to do business and is in good standing
as a foreign corporation in each jurisdiction where the ownership,
leasing or operation of its assets or properties or conduct of its
business requires such qualification, except where the failure to
be so organized, qualified or in such good standing, or to have
such power or authority, would not, individually or in the
aggregate, reasonably be expected to prevent, materially delay or
impair the ability of Parent and Merger Sub to consummate the
Merger and the other transactions contemplated by this Agreement.
Parent has made available to the Company a complete and correct
copy of the articles of incorporation and bylaws or comparable
governing documents of Parent and Merger Sub, each as in effect on
the date of this Agreement.
(b)
Corporate Authority . No further action, vote,
consent or approval of the direct or indirect holders of capital
stock of Parent is necessary to approve this Agreement and the
Merger and the other transactions contemplated hereby. Each of
Parent and Merger Sub has all requisite corporate power and
authority and has taken all corporate action necessary in order to
execute, deliver and perform its obligations under this Agreement,
subject only to the adoption of this Agreement by Parent as the
sole shareholder of Merger Sub, which adoption by Parent will occur
immediately following execution of this Agreement, and to
consummate the Merger. This Agreement has been duly executed and
delivered by each of Parent and Merger Sub and is a valid and
binding agreement of Parent and Merger Sub, enforceable against
each of Parent and Merger Sub in accordance with its terms, subject
to the Bankruptcy and Equity Exception.
(c)
Governmental Filings; No Violations; Etc .
(i)
Other than the filings and/or notices pursuant to
Section 1.3 and under the HSR Act, the ECMR and any
other applicable merger control laws (the “ Parent
Approvals ”), no notices, reports or other filings are
required to be made by Parent or Merger Sub with, nor are any
consents, registrations, approvals, permits or authorizations
required to be obtained by Parent or Merger Sub from, any
Governmental Entity in connection with the execution, delivery and
performance of this Agreement by Parent and Merger Sub and the
consummation by Parent and Merger Sub of the Merger and the other
transactions contemplated hereby, except those that the failure to
make or obtain would not, individually or in the aggregate,
reasonably be expected to prevent, materially delay or materially
impair the ability of Parent or Merger Sub to consummate the Merger
and the other transactions contemplated by this
Agreement.
(ii) The
execution, delivery and performance of this Agreement by Parent and
Merger Sub do not, and the consummation by Parent and Merger Sub of
the Merger and the other transactions contemplated hereby will not,
constitute or result in (A) a breach or violation of, or a
default under, the articles of incorporation or bylaws or
comparable governing documents of Parent or Merger Sub or the
comparable governing instruments of any of its Subsidiaries,
(B) with or without notice, lapse of time or both, a breach or
violation of, a termination (or right of termination) or a default
under, the creation or acceleration of any obligations or the
creation of a Lien on any of the assets of Parent or any of its
Subsidiaries pursuant to, any Contracts binding upon Parent or any
of its Subsidiaries or any Laws or governmental or non-governmental
permit or license to which Parent or any of its Subsidiaries is
subject or (C) any change in the rights or obligations of any
party under any of such Contracts, except, in the case of
clause (B) or (C) above, for any breach, violation,
termination,
17
default, creation, acceleration or
change that would not, individually or in the aggregate